1. Pink Sheet
  2. >>Market Access
  3. >>Government Payers
  4. >>Medicare

Stand-Alone PDP Market Lives to Fight Another Day, Enrollment Data Shows

 
• By Leslie Small

No mass exodus was seen from stand-alone prescription drug plans to Medicare Advantage drug plans between 2024 and 2025, according to one actuary.

Total PDP membership was largely flat after the enrollment period, in part because of the premium stabilization demo. (Shutterstock)
Key Takeaways
  • Stand-alone prescription drug plan did not see a rush of customers move to Medicare Advantage Prescription Drug plans between 2024 and 2025, despite expectations.
  • Total PDP membership was largely flat, in part because of the Biden Administration’s Part D premium stabilization demonstration.
  • Wellcare now has the largest share of PDP enrollment, but the top five carriers account for 95% of the individual PDP membership.

In defiance of some industry watchers’ expectations, no mass exodus from stand-alone Prescription Drug Plans (PDPs) to Medicare Advantage Prescription Drug (MA-PD) plans was observed between 2024 and 2025.

“Total enrollment was effectively flat from December [20]24 to February 2025,” said Brooks Conway, principal with Oliver Wyman. “That’s a little bit at odds with what some might have expected.”

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Medicare

More from Market Access

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

‘Tectonic’ Arkansas PBM Legislation May Upend Industry

 
• By Tim Casey

Industry will fight hard to prevent other states or the federal government from adopting measures similar to Arkansas' law preventing PBMs from owning pharmacies.